Advanced Cell Diagnostics Launches New Website And Online Store
Better serving the scientific community, the new site is equipped with a fresh design and interactivity, and features e-commerce capabilities
HAYWARD, CALIFORNIA, October 12, 2015: Advanced Cell Diagnostics Inc. (ACD), a technology and market leader in the field of molecular pathology and developer of cell and tissue-based RNA analysis tools, has announced the launch of its new website, www.acdbio.com. In response to the growing popularity of ACD’s proprietary RNAscope® in situ hybridization (ISH) technology, the site has been completely re-designed to better serve its thousands of monthly visitors. The new site graphically presents RNAscope technology, with streamlined navigation to interactively present all resources. New visitors can now rapidly and visually learn about the technology, see its applications and access relevant peer-reviewed publications. With fast and convenient e-commerce capabilities, ACD’s customers will also be able to access sales quotes in real time and place online orders, significantly easing the buying process.
In light of its ability to sensitively and specifically detect and quantify RNA targets in the context of the cell or tissue, RNAscope ISH is becoming an increasingly popular technology, with over 300 peer-reviewed publications to date featuring RNAscope ISH – currently at the rate of over 17 new publications per month. The new website reflects this business growth, together with the company’s continual dedication to customer service. Tom Olenic, Chief Commercial Officer of ACD, commented: “Of our monthly web visits, the majority are from scientists who are new to our technology, searching for how RNA ISH can enrich their research, so we prioritized visual presentation of our technology and diverse application content. On the other side, the sharp growth of our install base requires that we adopt modern B2B infrastructure to scale and ease the transactional processes. Scientists are busy; so searching through our 7,000 gene probe catalog, which grew by over 150% this past year, and selecting just the right probe for the right gene has to be fast and easy.”
ACD will continue to expand its online store features, soon to support customers outside of the US and also those who place orders using purchase orders. The new website is one facet of ACD’s initiative to incorporate modern business infrastructure to support and intimately interact with its growing customer base.
For more information, you can see the new website at www.acdbio.com.
About Advanced Cell Diagnostics
Advanced Cell Diagnostics, Inc. (ACD) is a leader in the field of molecular pathology, developing cell and tissue-based diagnostic tests for personalized medicine. The company’s products and services are based on its proprietary RNAscope® technology, the first automated multiplex chromogenic and fluorescent in situ hybridization platform capable of detecting and quantifying RNA biomarkers in situ at single-molecule sensitivity. RNAscope assays are currently used by thousands of customers, including all of the global top 10 pharmaceutical companies, world leading academic institutions and many cutting edge biotechnology companies to validate biomarkers for the management of cancer and other diseases. ACD’s industrial partnerships provide the foundation for ACD to develop companion diagnostic tests in conjunction with partners’ targeted therapeutics. ACD also pursues internal programs to develop and commercialize proprietary diagnostic tests in cancer management. Learn more about ACD and RNAscope technology at www.acdbio.com.
Help employers find you! Check out all the jobs and post your resume.
HAYWARD, CALIFORNIA, October 12, 2015: Advanced Cell Diagnostics Inc. (ACD), a technology and market leader in the field of molecular pathology and developer of cell and tissue-based RNA analysis tools, has announced the launch of its new website, www.acdbio.com. In response to the growing popularity of ACD’s proprietary RNAscope® in situ hybridization (ISH) technology, the site has been completely re-designed to better serve its thousands of monthly visitors. The new site graphically presents RNAscope technology, with streamlined navigation to interactively present all resources. New visitors can now rapidly and visually learn about the technology, see its applications and access relevant peer-reviewed publications. With fast and convenient e-commerce capabilities, ACD’s customers will also be able to access sales quotes in real time and place online orders, significantly easing the buying process.
In light of its ability to sensitively and specifically detect and quantify RNA targets in the context of the cell or tissue, RNAscope ISH is becoming an increasingly popular technology, with over 300 peer-reviewed publications to date featuring RNAscope ISH – currently at the rate of over 17 new publications per month. The new website reflects this business growth, together with the company’s continual dedication to customer service. Tom Olenic, Chief Commercial Officer of ACD, commented: “Of our monthly web visits, the majority are from scientists who are new to our technology, searching for how RNA ISH can enrich their research, so we prioritized visual presentation of our technology and diverse application content. On the other side, the sharp growth of our install base requires that we adopt modern B2B infrastructure to scale and ease the transactional processes. Scientists are busy; so searching through our 7,000 gene probe catalog, which grew by over 150% this past year, and selecting just the right probe for the right gene has to be fast and easy.”
ACD will continue to expand its online store features, soon to support customers outside of the US and also those who place orders using purchase orders. The new website is one facet of ACD’s initiative to incorporate modern business infrastructure to support and intimately interact with its growing customer base.
For more information, you can see the new website at www.acdbio.com.
About Advanced Cell Diagnostics
Advanced Cell Diagnostics, Inc. (ACD) is a leader in the field of molecular pathology, developing cell and tissue-based diagnostic tests for personalized medicine. The company’s products and services are based on its proprietary RNAscope® technology, the first automated multiplex chromogenic and fluorescent in situ hybridization platform capable of detecting and quantifying RNA biomarkers in situ at single-molecule sensitivity. RNAscope assays are currently used by thousands of customers, including all of the global top 10 pharmaceutical companies, world leading academic institutions and many cutting edge biotechnology companies to validate biomarkers for the management of cancer and other diseases. ACD’s industrial partnerships provide the foundation for ACD to develop companion diagnostic tests in conjunction with partners’ targeted therapeutics. ACD also pursues internal programs to develop and commercialize proprietary diagnostic tests in cancer management. Learn more about ACD and RNAscope technology at www.acdbio.com.
Help employers find you! Check out all the jobs and post your resume.